[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f8e3e3vEZAlr8ItkbinSnNp9_bju3r8qpGp5c8S7gPnY":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":33,"rows":40},"CES University",[4],29,false,1,5,8526,0,21,[14,17,20,22,24,26,28,30],{"name":15,"count":16},"Depression",3,{"name":18,"count":19},"Anxiety",2,{"name":21,"count":19},"Syncope",{"name":23,"count":8},"Chronic Obstructive Pulmonary Disease",{"name":25,"count":8},"Dyspnea",{"name":27,"count":8},"Sleep Bruxism, Childhood",{"name":29,"count":8},"Iron Deficiency",{"name":31,"count":8},"Constipation Chronic Idiopathic",[],[34,35,36,37,38,39],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[41,70,97,115,142,167,185,213,231,249,267,292,322,340],{"intervention":42,"totalTrials":8,"cells":43},"Mucograft",{"EARLY_PHASE1":44,"PHASE1":46,"PHASE2":48,"PHASE3":50,"PHASE4":52,"NA":68},{"trials":45,"activeCount":11},[],{"trials":47,"activeCount":11},[],{"trials":49,"activeCount":11},[],{"trials":51,"activeCount":11},[],{"trials":53,"activeCount":11},[54],{"nctId":55,"briefTitle":56,"status":57,"phases":58,"primaryCompletion":59,"completion":60,"start":61,"enrollment":62,"conditions":63,"interventions":67},"NCT02866929","A Biotype Enhancing Strategy For The Patient Undergoing Accelerated Orthodontics","UNKNOWN",[38],"2018-06","2018-09","2016-09",40,[64,65,66],"Class I Malocclusion","Other Periodontal Diseases","Thin Gingival Biotype",[42],{"trials":69,"activeCount":11},[],{"intervention":71,"totalTrials":8,"cells":72},"Bupivacaine-epinephrine",{"EARLY_PHASE1":73,"PHASE1":75,"PHASE2":77,"PHASE3":79,"PHASE4":81,"NA":95},{"trials":74,"activeCount":11},[],{"trials":76,"activeCount":11},[],{"trials":78,"activeCount":11},[],{"trials":80,"activeCount":11},[],{"trials":82,"activeCount":11},[83],{"nctId":84,"briefTitle":85,"status":86,"phases":87,"primaryCompletion":88,"completion":89,"start":90,"enrollment":62,"conditions":91,"interventions":93},"NCT03950700","Bupivacaine in the Treatment of Postoperative Pain of Impacted Third Molar Extraction","COMPLETED",[38],"2019-12-31","2020-01-01","2019-06-01",[92],"Teeth, Impacted",[71,94],"Saline Solution",{"trials":96,"activeCount":11},[],{"intervention":94,"totalTrials":8,"cells":98},{"EARLY_PHASE1":99,"PHASE1":101,"PHASE2":103,"PHASE3":105,"PHASE4":107,"NA":113},{"trials":100,"activeCount":11},[],{"trials":102,"activeCount":11},[],{"trials":104,"activeCount":11},[],{"trials":106,"activeCount":11},[],{"trials":108,"activeCount":11},[109],{"nctId":84,"briefTitle":85,"status":86,"phases":110,"primaryCompletion":88,"completion":89,"start":90,"enrollment":62,"conditions":111,"interventions":112},[38],[92],[71,94],{"trials":114,"activeCount":11},[],{"intervention":116,"totalTrials":8,"cells":117},"Ivermectin",{"EARLY_PHASE1":118,"PHASE1":120,"PHASE2":122,"PHASE3":136,"PHASE4":138,"NA":140},{"trials":119,"activeCount":11},[],{"trials":121,"activeCount":11},[],{"trials":123,"activeCount":11},[124],{"nctId":125,"briefTitle":126,"status":127,"phases":128,"primaryCompletion":129,"completion":129,"start":130,"enrollment":131,"conditions":132,"interventions":135},"NCT04602507","Ivermectin in Adults With Severe COVID-19.","TERMINATED",[36],"2021-12-09","2020-12-10",75,[133,134],"Covid19","Severe Acute Respiratory Syndrome",[116],{"trials":137,"activeCount":11},[],{"trials":139,"activeCount":11},[],{"trials":141,"activeCount":11},[],{"intervention":143,"totalTrials":8,"cells":144},"Clonidine",{"EARLY_PHASE1":145,"PHASE1":147,"PHASE2":149,"PHASE3":161,"PHASE4":163,"NA":165},{"trials":146,"activeCount":11},[],{"trials":148,"activeCount":11},[],{"trials":150,"activeCount":11},[151],{"nctId":152,"briefTitle":153,"status":57,"phases":154,"primaryCompletion":155,"completion":155,"start":156,"enrollment":157,"conditions":158,"interventions":159},"NCT01784250","Efficacy of Clonidine and Propranolol in Dentistry (AAA)",[36],"2013-04","2012-08",60,[18],[143,160],"Propranolol",{"trials":162,"activeCount":11},[],{"trials":164,"activeCount":11},[],{"trials":166,"activeCount":11},[],{"intervention":160,"totalTrials":8,"cells":168},{"EARLY_PHASE1":169,"PHASE1":171,"PHASE2":173,"PHASE3":179,"PHASE4":181,"NA":183},{"trials":170,"activeCount":11},[],{"trials":172,"activeCount":11},[],{"trials":174,"activeCount":11},[175],{"nctId":152,"briefTitle":153,"status":57,"phases":176,"primaryCompletion":155,"completion":155,"start":156,"enrollment":157,"conditions":177,"interventions":178},[36],[18],[143,160],{"trials":180,"activeCount":11},[],{"trials":182,"activeCount":11},[],{"trials":184,"activeCount":11},[],{"intervention":186,"totalTrials":8,"cells":187},"Levobupivacaine 0.5%: 20 ml",{"EARLY_PHASE1":188,"PHASE1":190,"PHASE2":192,"PHASE3":194,"PHASE4":196,"NA":198},{"trials":189,"activeCount":11},[],{"trials":191,"activeCount":11},[],{"trials":193,"activeCount":11},[],{"trials":195,"activeCount":11},[],{"trials":197,"activeCount":11},[],{"trials":199,"activeCount":11},[200],{"nctId":201,"briefTitle":202,"status":57,"phases":203,"primaryCompletion":204,"completion":205,"start":155,"enrollment":206,"conditions":207,"interventions":209},"NCT01734954","Comparison of Two Techniques of Sciatic Nerve Block With Levobupivacaine 0.5% in Orthopedic Surgery",[39],"2013-08","2013-09",66,[208],"Anesthesia",[186,210,211,212],"supplemental oxygen","Midazolam","Intravenous analgesics",{"intervention":210,"totalTrials":8,"cells":214},{"EARLY_PHASE1":215,"PHASE1":217,"PHASE2":219,"PHASE3":221,"PHASE4":223,"NA":225},{"trials":216,"activeCount":11},[],{"trials":218,"activeCount":11},[],{"trials":220,"activeCount":11},[],{"trials":222,"activeCount":11},[],{"trials":224,"activeCount":11},[],{"trials":226,"activeCount":11},[227],{"nctId":201,"briefTitle":202,"status":57,"phases":228,"primaryCompletion":204,"completion":205,"start":155,"enrollment":206,"conditions":229,"interventions":230},[39],[208],[186,210,211,212],{"intervention":211,"totalTrials":8,"cells":232},{"EARLY_PHASE1":233,"PHASE1":235,"PHASE2":237,"PHASE3":239,"PHASE4":241,"NA":243},{"trials":234,"activeCount":11},[],{"trials":236,"activeCount":11},[],{"trials":238,"activeCount":11},[],{"trials":240,"activeCount":11},[],{"trials":242,"activeCount":11},[],{"trials":244,"activeCount":11},[245],{"nctId":201,"briefTitle":202,"status":57,"phases":246,"primaryCompletion":204,"completion":205,"start":155,"enrollment":206,"conditions":247,"interventions":248},[39],[208],[186,210,211,212],{"intervention":212,"totalTrials":8,"cells":250},{"EARLY_PHASE1":251,"PHASE1":253,"PHASE2":255,"PHASE3":257,"PHASE4":259,"NA":261},{"trials":252,"activeCount":11},[],{"trials":254,"activeCount":11},[],{"trials":256,"activeCount":11},[],{"trials":258,"activeCount":11},[],{"trials":260,"activeCount":11},[],{"trials":262,"activeCount":11},[263],{"nctId":201,"briefTitle":202,"status":57,"phases":264,"primaryCompletion":204,"completion":205,"start":155,"enrollment":206,"conditions":265,"interventions":266},[39],[208],[186,210,211,212],{"intervention":268,"totalTrials":8,"cells":269},"Bupivacaina 0.5%",{"EARLY_PHASE1":270,"PHASE1":272,"PHASE2":274,"PHASE3":276,"PHASE4":278,"NA":280},{"trials":271,"activeCount":11},[],{"trials":273,"activeCount":11},[],{"trials":275,"activeCount":11},[],{"trials":277,"activeCount":11},[],{"trials":279,"activeCount":11},[],{"trials":281,"activeCount":11},[282],{"nctId":283,"briefTitle":284,"status":57,"phases":285,"primaryCompletion":286,"completion":286,"start":287,"enrollment":288,"conditions":289,"interventions":291},"NCT01596660","Transversus Abdominis Bilateral Plane Block in Total Laparoscopic Hysterectomy : A Randomized Controlled Trial",[39],"2012-05","2011-08",200,[290],"Block",[268],{"intervention":293,"totalTrials":8,"cells":294},"cephalosporin + Metronidazole Vaginal",{"EARLY_PHASE1":295,"PHASE1":297,"PHASE2":299,"PHASE3":301,"PHASE4":303,"NA":305},{"trials":296,"activeCount":11},[],{"trials":298,"activeCount":11},[],{"trials":300,"activeCount":11},[],{"trials":302,"activeCount":11},[],{"trials":304,"activeCount":11},[],{"trials":306,"activeCount":11},[307],{"nctId":308,"briefTitle":309,"status":57,"phases":310,"primaryCompletion":311,"completion":311,"start":312,"enrollment":313,"conditions":314,"interventions":320},"NCT03917134","Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy",[39],"2020-01-30","2019-05-01",600,[315,316,317,318,319],"Hysterectomy","Cellulitis","Vaginosis","Abscess","Cuff",[293,321],"cephalosporin + Placebos",{"intervention":321,"totalTrials":8,"cells":323},{"EARLY_PHASE1":324,"PHASE1":326,"PHASE2":328,"PHASE3":330,"PHASE4":332,"NA":334},{"trials":325,"activeCount":11},[],{"trials":327,"activeCount":11},[],{"trials":329,"activeCount":11},[],{"trials":331,"activeCount":11},[],{"trials":333,"activeCount":11},[],{"trials":335,"activeCount":11},[336],{"nctId":308,"briefTitle":309,"status":57,"phases":337,"primaryCompletion":311,"completion":311,"start":312,"enrollment":313,"conditions":338,"interventions":339},[39],[315,316,317,318,319],[293,321],{"intervention":341,"totalTrials":8,"cells":342},"Imiquimod",{"EARLY_PHASE1":343,"PHASE1":345,"PHASE2":347,"PHASE3":349,"PHASE4":351,"NA":353},{"trials":344,"activeCount":11},[],{"trials":346,"activeCount":11},[],{"trials":348,"activeCount":11},[],{"trials":350,"activeCount":11},[],{"trials":352,"activeCount":11},[],{"trials":354,"activeCount":11},[355],{"nctId":356,"briefTitle":357,"status":86,"phases":358,"primaryCompletion":359,"completion":204,"start":360,"enrollment":361,"conditions":362,"interventions":364},"NCT01935310","Photoaging Treatment With Imiquimod",[39],"2010-11","2010-07",17,[363],"Photoaging",[341]]